Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
Public ClinicalTrials.gov record NCT00117572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients With N2/N3 Locally Advanced Head and Neck Cancer
Study identification
- NCT ID
- NCT00117572
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- University of Chicago
- Other
- Enrollment
- 285 participants
Conditions and interventions
Conditions
Interventions
- chemotherapy Procedure
- cisplatin Drug
- docetaxel Drug
- fluorouracil Drug
- hydroxyurea Drug
- radiotherapy Procedure
Procedure · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2004
- Primary completion
- Nov 30, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Apr 8, 2018
2004 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USC University of Southern California Keck School of Medicine | Los Angeles | California | 90033 | — |
| UM Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Weiss Memorial Hospital | Chicago | Illinois | 60640 | — |
| Evanston Northwestern Healthcare | Evanston | Illinois | 60201 | — |
| Joliet Oncology Hematology Associates | Joliet | Illinois | 60435 | — |
| Fort Wayne Medical Oncology/Hematology Inc. | Fort Wayne | Indiana | 46815 | — |
| AP&S Clinic, LLC | Terre Haute | Indiana | 47807 | — |
| University of Kansas Cancer Center | Kansas City | Kansas | 66160 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Oncology Care Associates PLLC | Saint Joseph | Michigan | 49085 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Kansas City VA Medical Center | Kansas City | Missouri | 64128 | — |
| Roger Maris Cancer Center | Fargo | North Dakota | 58122 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| University of Tennessee Cancer Institute | Memphis | Tennessee | 38104 | — |
| UT Health Science Center at San Antonio | San Antonio | Texas | 78258 | — |
| Oncology Alliance | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00117572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2018 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00117572 live on ClinicalTrials.gov.